How DNA damage affects Golgi—the cell's shipping department

Jan 30, 2014

In studying the impact of DNA damage on the Golgi, a research team from the University of California, San Diego School of Medicine and the Ludwig Institute for Cancer Research have discovered a novel pathway activated by DNA damage, with important consequences for the body's cellular response to chemotherapy.

Standard cancer treatments, including many chemotherapy drugs and radiation therapy, act on by causing DNA damage. In many cancer cells, DNA damage turns on signaling pathways that lead to cell death – the basis of the use of these treatments for cancer.

A better understanding of the signaling pathways that are activated in cells in response to DNA damage, and the influence they exert to determine the fate of the cell to live or die, ultimately could lead to more effective use of these DNA damaging agents to treat cancer.

A study published in the January 30, 2014 issue of the journal Cell – led by Seth Field, MD, PhD, associate professor of medicine at UC San Diego School of Medicine – demonstrates that DNA damage triggers dramatic reorganization of the Golgi. The Golgi serves as the cell's processing center for the exportation of proteins, lipids and other large molecules to their final destinations outside of the cell. The researchers showed that, in mammalian cells, DNA damage triggers the Golgi to fragment and disperse throughout the cell.

In 2009, the research team had discovered a three-way interaction between a particular Golgi protein, GOLPH3, a lipid signaling molecule, PtdIns(4)P and a contractile protein, MYO18A. The link between the three applies a tensile force required for effective formation of the tubules and vesicles necessary for extracellular transportation.

Later screening identified GOLPH3 as an oncogene overexpressed in many human cancers, which can transform cells into tumorous cells. This study shows that common cancer therapeutic agents, by triggering DNA damage, activate GOLPH3.

Examining the mechanism of Golgi dispersal, the researchers discovered that Golgi dispersal in response to DNA damage involves a novel signaling pathway that directly links the DNA damage response to the Golgi.

The study also showed that the DNA damage-activated protein kinase, DNA-PK, directly modifies the Golgi protein GOLPH3 by phosphorylation on a specific site. This, in turn, enhances the interaction of GOLPH3 with MYO18A, increasing the tensile force applied to the Golgi, causing Golgi dispersal.

Interfering with Golgi dispersal after DNA damage by depletion of any of the components of this pathway – including DNA-PK, GOLPH3, or MYO18A – resulted in enhanced cell killing by DNA damaging agents. The scientists concluded that this pathway is normally required to allow cells to survive DNA damage.

"We further found that overexpression of GOLPH3, as is seen in human cancers, protects cells from killing by DNA damaging agents," said Field.

Identification of such a Golgi response reveals an unexpected pathway through DNA-PK, GOLPH3 and MYO18A that regulates cell survival following DNA damage, Field added. "This unappreciated feature of the cellular DNA damage response plays a significant role in determining cell survival."

Explore further: Disruptions in a protein-processing pathway appear to promote aggressive proliferation and invasion in tumor cells

Related Stories

Tracing the protein assembly line

Dec 20, 2013

Many newly synthesized proteins undergo a sequence of enzymatic modifications that enable them to do their jobs better. This process occurs within a series of membrane-bound structures called 'cisternae' ...

Recommended for you

How calcium regulates mitochondrial carrier proteins

Nov 26, 2014

Mitochondrial carriers are a family of proteins that play the key role of transporting a chemically diverse range of molecules across the inner mitochondrial membrane. Mitochondrial aspartate/glutamate carriers are part of ...

Team conducts unprecedented analysis of microbial ecosystem

Nov 26, 2014

An international team of scientists from the Translational Genomics Research Institute (TGen) and The Luxembourg Centre for Systems Biomedicine (LCSB) have completed a first-of-its-kind microbial analysis of a biological ...

Students create microbe to weaken superbug

Nov 25, 2014

A team of undergraduate students from the University of Waterloo have designed a synthetic organism that may one day help doctors treat MRSA, an antibiotic-resistant superbug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.